Results of Operations and Financial Condition · Regulation FD Disclosure
Item 2.02 Results of Operations and Financial Condition. On October 1, 2026, SINTX Technologies, Inc. (the “Company”) issued a press release announcing preliminary, unaudited revenue for the fiscal quarter ended September 30, 2026 and providing an update regarding the Company’s previously announced revenue guidance.…
Filed Oct 1, 2026Accepted Oct 1, 2026, 9:05 AM EDTCIK 1269026Accession 0001493152-26-045278
Headquartered in Salt Lake City, Utah, SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. SINTX’s technologies are supported by peer-reviewed research, a patent portfolio, U.S.-based manufacturing capabilities, and strategic industry relationships. The Company’s business includes proprietary biomaterials and medical device technologies, as well as contract manufacturing and other advanced ceramics opportunities. SINTX’s product portfolio includes the FDA-cleared SINAPTIC Foot & Ankle Implant System for reconstructive surgery.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 2.02Item 2.02 - Results of Operations
Item
2.02 Results of Operations and Financial Condition.
On
October 1, 2026, SINTX Technologies, Inc. (the “Company”) issued a press release announcing preliminary, unaudited revenue
for the fiscal quarter ended September 30, 2026 and providing an update regarding the Company’s previously announced revenue guidance.
The Company reported preliminary, unaudited revenue of approximately $2.2 million for the quarter ended September 30, 2026, of which
approximately $2.1 million was derived from product sales.
The
preliminary financial information described above is based on information currently available to management and remains subject to completion
of the Company’s quarter-end financial close and review procedures.
A
copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item
7.01. Regulation FD Disclosure.
As
described in the press release furnished as Exhibit 99.1, based on the preliminary quarterly revenue described under Item 2.02 above,
the Company intends to deliver a Call Notice to the holders of its outstanding Class B Common Stock Purchase Warrants (the “Class
B Warrants”) pursuant to the terms of the Class B Warrants.
The
Class B Warrants provide the Company with the right to call for exercise all or a portion of the outstanding Class B Warrants upon the
Company reporting Quarterly Revenue, as defined in the Class B Warrants, of at least $2.0 million for a fiscal quarter in a qualifying
Revenue Evidence Filing. The Company has determined that approximately $2.1 million of its revenue for the quarter ended September 30,
2026 constitutes Quarterly Revenue for purposes of the Class B Warrants.
The
press release also includes information regarding the Company’s fourth-quarter 2026 revenue outlook and certain business and operational
developments.
The
information furnished pursuant to Items 2.02 and 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed
“filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or
otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Filed exhibits (1)
EX-99.1 (by filename) ex99-1.htm
Exhibit
99.1
SINTX
Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance
Third-quarter
revenue grows roughly 380% from Q2, driven by stronger-than-expected industrial sales to Fortune 500 customers; Company reiterates Q4 revenue
guidance
Revenue
milestone also enables Company to call Class B warrants
SALT
LAKE CITY, Utah - October 1, 2026 - SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”),
a leader in advanced silicon nitride biomaterials and ceramics for medical and industrial applications, today announced preliminary,
unaudited revenue of $2.2 million* for the third quarter ended September 30, 2026. The result exceeds the high end of the Company’s
previously announced guidance of $0.9 million to $1.1 million, reflecting stronger-than-expected industrial ceramics sales, and is expected
to result in narrower losses than previous quarters.
Sales
of industrial parts to aerospace subsidiaries of Fortune 500 companies accounted for the majority of third-quarter revenue. During the
quarter, SINTX began shipments against the more than $3.2 million in contract manufacturing purchase orders announced in June,
converting a portion of those orde…